Medidata and Medpace Sign Agreement to Integrate Data into Platform
Medidata has announced that Medpace Inc. has entered into an agreement to integrate Medidata Rave Imaging with Medpace's imaging systems and workflow. This will create a platform for capturing, managing, analyzing, and storing images and imaging data for clinical trials. Features include image capture, advanced edit checks, workflow, form design, electronic data capture connection, and intelligent archiving.
To learn more, click here.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
